Wall Street delivered a split verdict on Monday. Starbucks received a consensus upgrade as analysts lifted their average target price to $111.55. The coffee giant carries a $120 billion market cap. Short interest sits at just 3.3% of free float — bears are not rushing in.
Fair Isaac Corporation was the day's most notable downgrade. The FICO scoring firm saw consensus slip from 4 holds to 5. Its average target price fell to $1,497. Short interest of 10.3% of free float is elevated for a fintech. The downgrade suggests analysts see limited upside after strong recent gains.
Healthcare was busy on the positive side. Incyte Corporation and DexCom both received target price hikes. Incyte's average target climbed to $124.26. DexCom's moved to $93.44.
Real estate drew attention too. Invitation Homes and Welltower both saw targets raised. joined them with a modest bump to $157.60.
Insurance broker Brown & Brown and risk consultant Willis Towers Watson both collected higher targets. Staples names Colgate-Palmolive and Church & Dwight also saw upward revisions. Asset manager T. Rowe Price was the lone target cut in the group, slipping to $108.67.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
